ICAN at a Glance Mission Overview History and Philosophy Accomplishments Innovative Organization Testimonials

Cancer Reference/Education Clinical Trials/Education Late-Breaking News Cancer News by Type Diagnostic Imaging News Palliative Care/Hospice News Stem Cell Research News Nanotechnology News Biomarker News Nutrition and Vitamins News Pain Management News

ICAN Cancer Program Areas Named Patient Programs Cancer Patient Advocacy Programs Clinical Trials Advocacy Programs ICAN's Customized Advocacy Drug Discovery Initiatives ICAN's FDA Representative/Blog

Board and Council Responsibilities Board Governance Board Leadership Executive Leadership ICAN Brain Trust Join Us as a Volunteer

Upcoming Events Golf Tournament Fall Casino Party Trash and Treasure Sales Salon Concerts Marathon Friends of ICAN Event Highlights

Attention HR &
Hiring Mangers:

Click here to learn how you can donate money without spending anything.

"You were a Godsend at a very scary time in his, and our, lives. Male breast cancer is very rare, and without your help and guidance we wouldn't have had a clue where to turn. I am happy to say that my dad did NOT die of cancer... Thanks again!"

Leukemia/Lymphoma News

Cancer treatment 'blows tumours away in weeks'

Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium

Seattle Genetics Receives FDA Fast Track Designation For SGN-35 For The Treatment Of Hodgkin Lymphoma

The news headlines shown above for Lymphoma / Leukemia are provided courtesy of Medical News Today.